# MannKind Corporation

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/mannkind-corporation/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | biopharmaceutical company |
| OpenAlex ID | https://openalex.org/F4320315142 |
| ROR ID | https://ror.org/02vbfm330 |
| Works | 484 |

## Funder papers

- [Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes](https://scholariq.org/papers/glucose-control-and-vascular-complications-in-veterans-with-type-2-diabetes/)
- [Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity](https://scholariq.org/papers/effect-of-continued-weekly-subcutaneous-semaglutide-vs-placebo-on-weight-loss/)
- [Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial](https://scholariq.org/papers/long-term-kidney-outcomes-of-semaglutide-in-obesity-and-cardiovascular-disease/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.